Marinus Pharmaceuticals Inc_INT buy stratec
Start price
15.02.18
/
50%
€22.48
Target price
15.02.19
€43.30
Performance (%)
-40.61%
End price
15.02.19
€13.35
Summary
This prediction ended on 15.02.19 with a price of €13.35. Massive losses of -40.61% were the result for the BUY prediction by stratec. stratec has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Marinus Pharmaceuticals Inc_INT | - | - | - | - |
| iShares Core DAX® | 3.901% | 2.667% | 5.690% | 53.464% |
| iShares Nasdaq 100 | -2.603% | -7.934% | 19.505% | 72.276% |
| iShares Nikkei 225® | -0.545% | -9.754% | 46.053% | 63.079% |
| iShares S&P 500 | -0.881% | -1.488% | 16.911% | 60.400% |
Comments by stratec for this prediction
In the thread Marinus Pharmaceuticals Inc diskutieren
Marinus entwickelt Behandlungsmöglichkeiten für Patienten mit Epilepsie und neurologischen Erkrankungen.
- Marinus Pharmaceuticals (NASDAQ:MRNS) initiated with Buy rating and $33 (443% upside) price target at H.C. Wainwright.
20.03.2018:
- Marinus Pharmaceuticals (NASDAQ:MRNS) initiated with Buy rating and $13 (201% upside) price target at Mizuho Securities.
(Laufzeit überschritten)